openPR Logo
Press release

Biopharmaceutical Contract Manufacturing Market Revenue, Opportunity, Segment and Key Trends 2017-2027

03-03-2017 11:18 AM CET | Health & Medicine

Press release from: Future Market Insights

Biopharmaceutical Contract Manufacturing Market Revenue,

Biopharmaceuticals are biological preparations which are intended to treat range of diseases. The market for biopharmaceuticals is robust with the availability of several biologics, biosimilars, and biobetters in the market. Biopharmaceutical contract manufacturing services include development of large and small biologics from stage of clinical development to commercial scale. Contract Manufacturing Organizations (CMO) offers wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization. The success of CMO measured by its production capacity and reproducibility. Biopharmaceutical CMOs must over the complexity of large molecule manufacturing through sophisticated cell line development, cell culture manufacturing and quality control. Apart from developmental services, several biopharmaceutical contract manufacturing organizations offers marketing, regulatory and analytical expertise to the clients.

Biopharmaceutical Contract Manufacturing Market: Drivers and Restraints

Global biopharmaceutical contract manufacturing market is continue to witness positive growth owing to growing demand for outsourced services in pharmaceutical industry and rising investments by pharmaceutical and biotechnological companies in research and developmental activities for biologics would expected to fuel demand for biopharmaceutical outsourcing over the forecast period. The market for biopharmaceutical outsourcing driven by both biologics and biosimilars. Exiting developmental pipeline across multiple therapies, rise in venture capital funding, increasing regulatory approvals for biologics and orphan drugs will help to bolster growth of biopharmaceutical contract manufacturing market. Increasing pressure from governments, patient groups, and general public for affordable and sustainable model of pricing, which prompt developer to outsource the development process to reduce cost of development and this in turn boost the biopharmaceutical contract manufacturing market positively over forecasted period. However, increasingly stringent regulations, which increases the overhead cost, time to market and meagre venture funding for early stage clinical development companies may hamper the growth of the biopharmaceutical outsourcing market over the forecast period.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2982

Biopharmaceutical Contract Manufacturing Market: Segmentation

Global biopharmaceutical contract manufacturing market has been segmented on the basis of manufacturing process, services, drug type, and molecule type, phase of development, end user and region.

Based on the manufacturing process, the global biopharmaceutical contract manufacturing market is segmented into the following:

Mammalian Based Manufacturing

Microbial Based Manufacturing

Based on the services, the global biopharmaceutical contract manufacturing market is segmented into the following:

Fill and Finish Services

Cell banking

Analytical Services

Formulation

Down streaming Process

Process Development

Based on the drug type, the global biopharmaceutical contract manufacturing market is segmented into the following:

New Biological Entities (NBE)

Biosimilars

Based on the molecule type, the global biopharmaceutical contract manufacturing market is segmented into the following:

Large Molecules

Small Molecule Biologics

Based on the phase of development, the global biopharmaceutical contract manufacturing market is segmented into the following:

Preclinical

Phase I

Phase II

Phase III

Phase IV (Post Marketing Surveillance)

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2982

Based on the end user, the global biopharmaceutical contract manufacturing market is segmented into the following:

Bio-Pharmaceutical companies

Pharmaceutical Companies

Drug Discovery Companies

Biopharmaceutical Contract Manufacturing Market: Overview

Global biopharmaceutical contract manufacturing market is highly competitive where the speed to market is imperative along with efficient process and low costs. Market for biopharmaceutical contract manufacturing is consistently witnessing newer challenges as several drug discovery and biopharmaceutical companies increasingly demanding for newer services like production, formulation, analytical services apart from conventional services. As there is growing demand for drugs for smaller indications (like orphan) players in the market need to create small production batches which creates flexibility in the manufacturing process.

Biopharmaceutical Contract Manufacturing Market: Region-wise Outlook

Geographically, biopharmaceutical contract manufacturing market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for biopharmaceutical contract manufacturing market. Europe region is expected to witness strong growth owing to increased approval of biosimilars by the regulators in the market. Asia Pacific is anticipated to register positive growth owing to presence of several small players offering different services, low cost of development, and availability of skilled manpower and expertise in the region.

Biopharmaceutical Contract Manufacturing Market: Key Players

Some players in biopharmaceutical contract manufacturing market include Lonza Group Ltd., Boehringher ingelheim, Sandoz, Fujifilm Diosynth Biotechnology, Rentschler Biotechnologie, Celonic GmbH, BIOMEVA GmbH, ProBioGen AG to name a few.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing Market Revenue, Opportunity, Segment and Key Trends 2017-2027 here

News-ID: 455582 • Views:

More Releases from Future Market Insights

AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Rising Digital Transformation
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Advanced Technology Integration
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels. As e-commerce continues to penetrate global
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Technological Innovation
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications. The expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Security Infrastructure Expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031" The global Biopharmaceutical third-party logistics market
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030. The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial